<DOC>
	<DOCNO>NCT01191086</DOCNO>
	<brief_summary>The purpose study examine safety USL255 adjunctive therapy patient refractory partial onset-seizures .</brief_summary>
	<brief_title>Open-label Extension Study Evaluate Safety USL255 Patients With Refractory Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Have complete maintenance period P09004 study . Continue treat stable dose 1 maximum 3 approve concomitant AEDs .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>partial onset seizure</keyword>
	<keyword>adjunctive therapy</keyword>
</DOC>